FHB
AMPH icon

First Hawaiian Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

First Hawaiian Bank’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,519
Closed -$268K – 874
2024
Q3 		$268K Hold
5,519
– – 0.01% 766
2024
Q2 		$221K Sell
5,519
-345
-6% -$14.3K 0.01% 746
2024
Q1 		$257K Hold
5,864
– – 0.01% 708
2023
Q4 		$363K Buy
+5,864
New +$308K 0.01% 673

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

First Hawaiian Bank's AMPH Position: Q4 2024 in Review

First Hawaiian Bank sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2024, closing a stake of 5,519 shares — an estimated $268K sold.

First Hawaiian Bank first reported a position in AMPH in Q4 2023 and held it in 4 quarters. The position peaked at $363K in Q4 2023. 263 funds tracked by Wall St. Rank hold AMPH as of Q4 2024.

  • First Hawaiian Bank reported no remaining Amphastar Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • First Hawaiian Bank sold 5,519 Amphastar Pharmaceuticals shares in Q4 2024, an estimated $268K.
  • First Hawaiian Bank first reported a position in Amphastar Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • First Hawaiian Bank's Amphastar Pharmaceuticals position peaked at $363K in Q4 2023.
  • 263 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2024.

Based on First Hawaiian Bank's 13F filing for Q4 2024, filed 8 Jan 2025.